Outcomes

The available evidence for human growth hormone (HGH/somatropin) outcomes is limited and primarily focused on pediatric growth conditions, with some emerging data on other applications.

Growth-Related Outcomes in Children

Turner Syndrome: One retrospective cohort study examined recombinant human growth hormone therapy in children with Turner syndrome, reporting on efficacy and identifying influencing factors for treatment response. However, specific outcome measures and effect sizes are not detailed in the available evidence.

Growth Hormone Deficiency vs. Idiopathic Short Stature: A comparative study analyzed differences in response to long-acting growth hormone therapy between patients with growth hormone deficiency (GHD) and idiopathic short stature (ISS), along with influencing factors. The strength of evidence is limited as specific outcome data are not provided.

Familial Short Stature: A case report documented therapeutic response to recombinant human growth hormone in a patient with a novel NPR2 gene variant and familial short stature, though this represents only anecdotal evidence.

Safety Considerations

Scoliosis Risk: One study investigated a dose-response relationship between growth hormone treatment and scoliosis development in children with short stature, suggesting potential skeletal complications, though specific risk quantification is not available from the current evidence.

Other Applications

Intestinal Failure: A completed Phase 4 trial (NCT01380366) examined recombinant human growth hormone effects on intestinal permeability in intestinal failure patients, though outcomes are not reported in the available data.

Limitations of Current Evidence

The evidence base is notably limited, with most studies being observational rather than randomized controlled trials. Specific outcome measures, effect sizes, statistical significance, and follow-up durations are not provided in the available abstracts. The majority of evidence focuses on pediatric populations with growth disorders.

Disclaimer: This summary is for informational purposes only and should not replace consultation with qualified healthcare providers for individual medical decisions.

Human Growth Hormone (HGH/Somatropin)

Member access required